跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOSTATIN 50 microgram/1mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
SANDOSTATIN 50 microgram/1mL injection ampoule
Approved
STANDARD
SANDOSTATIN 50 microgram/1mL injection ampoule
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
bc685da5dfe2f704
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
bc685da5dfe2f704
Product Name
SANDOSTATIN 50 microgram/1mL injection ampoule
Artg Id
42192
Artg Name
SANDOSTATIN Octreotide 50 microgram/1mL injection ampoule
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
1993-01-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-04831-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-PI-00283-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
bc685da5dfe2f704
Type
Standard
Back to TGA Approvals